Umalsa, Charitie M.
HRN: 03-03-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/16/2022
04/22/2022
IVT
500mg
Q8
T/C Endometritis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes